The results confirmed that down-regulation of ACACA in prostate cancer cells affected the mitochondrial potential by mitigating the balance of NAD+/NADH, mitochondria ATP production, mtDNA, and ROS levels, which decreased the proliferation capacity of tumor cells. The gene discussed is ACACA; the disease is Familial prostate cancer.